| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | GSK 626616 |
|---|
| Description | Potent and selective DYRK inhibitor (IC50 = 0.7 nM for DYRK3, similar potency for DYRK1 and 2). Exhibits ~20-fold selectivity over casein kinase 2 and negligible activity against a panel of 451 kinases screened. Enhances number of CFU-E stimulated by Epo from human marrow. Increases hemoglobin levels in anemic mice. Orally bioavailable. Purity 98%. MW (observed): 401.27 |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | (5Z)-2-[(2,6-Dichlorophenyl)amino]-5-(6-quinoxalinylmethylene)-4(5H)-thiazolone |
|---|
| Gene, Accession, CAS # | CAS: 1025821-33-3 |
|---|
| Catalog # | 6638/50 |
|---|
| Price | |
|---|
| Order / More Info | GSK 626616 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|